PT-141

PT-141, also known as bremelanotide in clinical literature, is a synthetic melanocortin receptor agonist derived from melanotan research. It is studied primarily for central nervous system melanocortin signaling rather than direct vascular mechanisms. Research interest focuses on MC4R-associated pathways, sexual-behavior models, neuroendocrine signaling, and the broader role of melanocortin receptors in appetite, stress, pigmentation, and autonomic regulation.

PT-141 is researched for activity at melanocortin receptors, particularly MC4R and related receptor subtypes. Melanocortin receptors are G-protein-coupled receptors involved in central regulation of energy balance, autonomic tone, and sexual-function signaling. Unlike compounds that primarily act through peripheral blood-flow mechanisms, PT-141 research emphasizes central receptor signaling and neuroendocrine pathways.

• MC4R-mediated central nervous system signaling.
• Sexual-behavior and arousal models in neuroendocrine research.
• Melanocortin receptor subtype selectivity and downstream signaling.
• Interactions between appetite, stress, autonomic tone, and reproductive signaling.
• Comparative research with other melanocortin-related compounds.

• Hadley ME and Dorr RT. Melanocortin peptide therapeutics: historical milestones and clinical studies. Peptides, 2006.
• King SH et al. Melanocortin receptor agonists and sexual function research. International Journal of Impotence Research, 2007.
• Cone RD. Anatomy and regulation of the central melanocortin system. Nature Neuroscience, 2005.